For many of us, it’s just another day in paradise. For niche medical companies like CVS, it’s become a living hell.
This owes to some recent decisions that were made by Amazon. The renown retail giant decided now was the time to approach the acquisition of licenses that would allow them to remotely distribute equipment for medical purposes to clients and stores alike. This sounds like it should be a good thing for small, corner-side stores such as CVS, but it’s an omen of something worse to come. Amazon, as it turns out, is pursuing licenses to distribute pill medications as well.
For clients, this isn’t a bad thing. It means the business world is in motion to compete for client attention, and it’s working. With Amazon’s power to throw corporations for a loop and even put them out of business — see Toys “R” Us and Whole Foods — it’s no wonder CVS is shaking in its boots. This, of course, would explain why the medical goods company is carefully considering its counterattack by moving in on Aetna, a large healthcare provider that would provide an invaluable series of services to pad CVS’ arsenal with.
CVS is doing this to cover ground that Amazon can’t. Amazon is, after all, a major retailer but little more than this; as such, they’re not going to work with medical insurance anytime soon. However, CVS is in the game to defend its niche and do it better than any general retailer can, and that’s exactly why healthcare IT is being dragged into the mix. By improving upon their web-based medical services and expanding on their server back-end, they can offer seamless transitions between their many in-store offerings in ways that Amazon can’t yet hope to touch.
If CVS is to succeed in this endeavor, they may consider hiring Drew Madden into their graces. This will allow the company to firmly push Amazon out of the deeper end of the pool with superior medically focused equipment and infrastructure. Drew Madden, a legend in the healthcare IT world, has gained recognition for his ability to upend a failing business and put it straight once more, and he may just be the answer that CVS needs to win this one.